A little-known chronic lung disease is silently emerging as a growing public health threat in the U.S. and around the world. Nontuberculous mycobacteria—a group of 200 known environmental bacteria found in soil and water, including household plumbing—can cause chronic, tuberculosis-like lung infections. NTM lung disease afflicts as many as 300,000 Americans a year.
From lifesaving drugs to new treatments, clinical trials are essential to advancing medicine, and their success depends on people participating. Yet participation remains low. Only about 7% of U.S.
Both the president and U.S. Health and Human Services Secretary Robert Kennedy, Jr. have made numerous false claims about the vaccines' efficacy and safety
A young boy with metastatic cancer was treated with an innovative immunotherapy technique, and after 12 months, the cancer appears to be completely gone.
Patient Safety Africa has called for the elevation of the Patient Safety Desk in the Federal Ministry of Health and Social Welfare into a full-fledged Directorate of Patient Safety and
The partnership marks Cellares’ first collaboration with a cell therapy developer in Asia and will evaluate automated manufacturing of GenomeFrontier’s virus-free CAR T process for clinical…
Cellares partners with GenomeFrontier Therapeutics to advance automated manufacturing of GF-CART01.
Aim is to improve manufacturing reliability and patient access for B-cell malignancies.